SOM Biotech stands for Responsible Innovation

posted on June 7, 2017

SOM Biotech is one of the European companies participating in the EU Compass program, Biomedicine field. COMPASS is an EU-funded project that supports Small and Medium-sized Enterprises (SMEs) in three emerging technology industries in order to manage their research, development and innovation activities in a responsible and inclusive manner.

Dr. Esteva, SOM’s Operations Manager, takes part in COMPASS, the EU-funded project, together  with group of Responsible Innovation pioneers, that aims to advance the understanding of Responsible Innovation in the nanotechnology, cyber security (infosec) and biomedicine sectors. The labs engage SMEs in a five-step series of online and offline interactive workshops in order to develop future guidelines towards Responsible Innovation in each field. These labs will be all about co-creation and experimentation of new practices. They will allow companies to look at their own practices and methods to see what improvements can be made in order to maximize mid to long term profits or extend their markets through becoming more receptive to the needs of customers and users.

Further information at